Latest data from July 29, 2022
Number of Health Center respondents = 39 (83% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 6,787 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 66.12% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 1,887 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 64.36% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 31.32% | 33.55% |
| White, Hispanic/Latino Patients | 23.31% | 25.23% |
| Black/African American, Non-Hispanic/Latino Patients | 27.69% | 27.98% |
| Black/African American, Hispanic/Latino Patients | 1.56% | 1.27% |
| Asian Patients3 | 1.09% | 1.06% |
| American Indian/Alaska Native Patients3 | 0.38% | 0.26% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.91% | 0.69% |
| Patients with More Than One Race3 | 2.89% | 0.64% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.30% | 3.44% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 2.08% | 1.59% |
| Unreported/Refused to Report Race and Ethnicity | 5.47% | 4.29% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 755 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 78.91% |
| COVID-19 Immunization Series Completed | 615 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 69.49% |
| COVID-19 Immunization Series Additional | 1,015 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 72.31% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 20.53% | 29.92% | 26.90% |
| White, Hispanic/Latino Patients | 33.25% | 29.11% | 25.12% |
| Black/African American, Non-Hispanic/Latino Patients | 27.55% | 22.76% | 35.17% |
| Black/African American, Hispanic/Latino Patients | 1.19% | 2.28% | 1.97% |
| Asian Patients3 | 0.79% | 1.79% | 1.28% |
| American Indian/Alaska Native Patients3 | 0.26% | 0.00% | 0.30% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.79% | 0.65% | 0.20% |
| Patients with More Than One Race3 | 5.96% | 6.99% | 2.46% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 7.02% | 4.55% | 3.74% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.79% | 0.81% | 0.89% |
| Unreported/Refused to Report Race and Ethnicity | 1.85% | 1.14% | 1.97% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 33.33% |
| 1 to 24 Hours | 20.51% |
| More Than 24 Hours | 43.59% |
| N/A | 2.56% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 5.13% |
| Staffing to administer the vaccine | 10.26% |
| Vaccine confidence | 41.03% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 2.56% |
| Other | 7.69% |
| None | 38.46% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 61.54% |
| Average Percent of Health Center Visits Conducted Virtually | 14.74% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 33.33% |
| Number of Mobile Van Sites | 16 |
| Number of Pop-up Clinics | 8 |
| Number of School-Based Vaccination Sites | 1 |
| Number of Family Vaccination Clinics | 12 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 12.82% |
| Refer patients to another organization that provides monoclonal antibody therapies | 35.90% |
| None | 51.28% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 7.69% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 28.21% |
| Therapy administration/onsite logistics | 15.38% |
| Other | 10.26% |
| None | 48.72% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 30 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 10,508 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 83.33% |
| Provided to General Public Who Came to the Health Center | 63.33% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 16.67% |
| Provided at Other Community Events | 36.67% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 16.67% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 23.33% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 13.33% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 13.33% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 6.67% |
| Other | 6.67% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 20 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 10,746 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 95.00% |
| Provided to General Public Who Came to the Health Center | 65.00% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 25.00% |
| Provided at Other Community Events | 35.00% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 15.00% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 15.00% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 15.00% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 5.00% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 10.00% |
| Other | 0.00% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 14 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 54.46% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 37.62% |
| White, Hispanic/Latino Patients | 30.20% |
| Black/African American, Non-Hispanic/Latino Patients | 15.35% |
| Black/African American, Hispanic/Latino Patients | 0.50% |
| Asian Patients3 | 1.49% |
| American Indian/Alaska Native Patients3 | 0.00% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
| Patients with More Than One Race3 | 0.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 6.93% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.99% |
| Unreported/Refused to Report Race and Ethnicity | 6.93% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 3.96% |
| Patients Experiencing Homelessness | 2.97% |
| Patients Who Are Residents of Public Housing | 1.98% |
| Patients with Limited English Proficiency | 15.84% |
| Children Under 18 Years of Age | 5.94% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: